Active Wipes
NDC Package 84323-009-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Active Wipes is wet hands thoroughly with wipe • allow to dry without rinsing. Marketed by Zhejiang Starryapex Biotechnology Co.,ltd., this product is identified by NDC 84323-009 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
84323-009-01
Package Description
1500 PATCH in 1 BAG / 3 g in 1 PATCH
Product Code
11-Digit Billing Format
84323000901

Clinical Specifications

Proprietary Name
Active Wipes
Dosage Form
-
Usage Information
Wet hands thoroughly with wipe • allow to dry without rinsing

Regulatory & Marketing

Labeler Name
Zhejiang Starryapex Biotechnology Co.,ltd.
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-22-2026
End Marketing Date
06-08-2026
Listing Expiration
06-08-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84323-009-01 identifies a specific commercial package of 1500 patch in 1 bag / 3 g in 1 patch of Active Wipes, labeled by Zhejiang Starryapex Biotechnology Co.,ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zhejiang Starryapex Biotechnology Co.,ltd. on May 22, 2026. The current certification is valid through June 08, 2026.

How is this Zhejiang Starryapex Biotechnology Co.,ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84323000901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84323-009-01
11-Digit CMS (5-4-2)
84323-0009-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.